Genotype A HBV (hepatitis B virus) cases on the rise in Japan
This article was originally published in Clinica
Executive Summary
Incidence of the hepatitis B (HBV) virus genotype A usually associated with Europe and North America is on the increase in Japan, say local scientists. The rise in the number of cases is surprising because the majority of hepatitis cases in Japan are usually of the genotype C. Hiroshi Yatsuhashi, director at the Institute for Clinical Research at the National Nagasaki Medical Center, has therefore claimed that much of the infection has occurred through sexual contact with people "including foreigners" in urban areas.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.